HBT LABS INC
GenericsHBT LABS INC is a generic drug manufacturer focused on Oncology.
HBT LABS INC's Key Drugs
HBT LABS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
HBT LABS INC's Recent FDA Approvals
New NDA/BLA approvals for HBT LABS INC over the last two years — novel drugs only, excluding generics and label supplements.
HBT LABS INC's Therapeutic Areas
HBT LABS INC's approved drugs and pipeline span 1 therapeutic area, led by Oncology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
HBT LABS INC's Top Competitors
HBT LABS INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
HBT LABS INC Pipeline Snapshot
Active clinical trials for HBT LABS INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2019-11-21
- Latest
- 2021-05-28
- Applications
- 1